Apigenin’s Health Benefits in Kidney Disease: Pharmacological Insights and Future Perspectives

References

• Jager, K. J.; Kovesdy, C.; Langham, R.; Rosenberg, M.; Jha, V.; Zoccali, C. A Single Number for Advocacy and Communication—Worldwide More Than 850 Million Individuals Have Kidney Diseases. Kidney Int. 2019, 96(5), 1048–1050. DOI: 10.1016/j.kint.2019.07.012.
   PubMed Web of Science ®Google Scholar
• Liu, Q.; Chen, J.; Zeng, A.; Song, L. Pharmacological Functions of Salidroside in Renal Diseases: Facts and Perspectives. Front. Pharmacol. 2024, 14. DOI: 10.3389/fphar.2023.1309598.
   Google Scholar
• Chen, D.-Q.; Hu, H.-H.; Wang, Y.-N.; Feng, Y.-L.; Cao, G.; Zhao, Y.-Y. Natural Products for the Prevention and Treatment of Kidney Disease. Phytomed. Int. J. Phytother. Phytopharm. 2018, 50, 50–60. DOI: 10.1016/j.phymed.2018.09.182.
   PubMed Web of Science ®Google Scholar
• Ekrikpo, U.; Obiagwu, P.; Chika-Onu, U.; Yadla, M.; Karam, S.; Tannor, E. K.; Bello, A. K.; Okpechi, I. G. Epidemiology and Outcomes of Glomerular Diseases in Low- and Middle-Income Countries. Semin. Nephrol. 2022, 42(5), 151316. DOI: 10.1016/j.semnephrol.2023.151316.
   PubMedGoogle Scholar
• Zoccali, C.; Mallamaci, F.; Lightstone, L.; Jha, V.; Pollock, C.; Tuttle, K.; Kotanko, P.; Wiecek, A.; Anders, H. J.; Remuzzi, G., et al. A New Era in the Science and Care of Kidney Diseases. Nat. Rev. Nephrol. 2024, 20(7), 460–472. DOI: 10.1038/s41581-024-00828-y.
   PubMedGoogle Scholar
• Wang, J.; Lin, Y.; Chen, X.; Liu, Y.; Zhou, T. Mesenchymal Stem Cells: A New Therapeutic Tool for Chronic Kidney Disease. Front. Cell. Dev. Biol. 2022, 10, 910592. DOI: 10.3389/fcell.2022.910592.
   PubMedGoogle Scholar
• Zhou, T.; Yuan, Z.; Weng, J.; Pei, D.; Du, X.; He, C.; Lai, P. Challenges and Advances in Clinical Applications of Mesenchymal Stromal Cells. J. Hematol. Oncol. 2021, 14(1), 24. DOI: 10.1186/s13045-021-01037-x.
   PubMed Web of Science ®Google Scholar
• Yang, B.; Xie, Y.; Guo, M.; Rosner, M. H.; Yang, H.; Ronco, C. Nephrotoxicity and Chinese Herbal Medicine. Clin. J. Am. Soc. Nephrol. CJASN. 2018, 13(10), 1605–1611. DOI: 10.2215/CJN.11571017.
   PubMed Web of Science ®Google Scholar
• Zhao, M.; Yu, Y.; Wang, R.; Chang, M.; Ma, S.; Qu, H.; Zhang, Y. Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease. Front. Pharmacol. 2021, 11, 619201. DOI: 10.3389/fphar.2020.619201.
   PubMed Web of Science ®Google Scholar
• Vargas, F.; Romecín, P.; García-Guillén, A. I.; Wangesteen, R.; Vargas-Tendero, P.; Paredes, M. D.; Atucha, N. M.; García-Estañ, J. Flavonoids in Kidney Health and Disease. Front. Physiol. 2018, 9. DOI: 10.3389/fphys.2018.00394.
   Google Scholar
• Ahmed, S. A.; Parama, D.; Daimari, E.; Girisa, S.; Banik, K.; Harsha, C.; Dutta, U.; Kunnumakkara, A. B. Rationalizing the Therapeutic Potential of Apigenin Against Cancer. Life Sci. 2021, 267, 118814. DOI: 10.1016/j.lfs.2020.118814.
   PubMed Web of Science ®Google Scholar
• Nezu, M.; Suzuki, N. Roles of Nrf2 in Protecting the Kidney from Oxidative Damage. Int. J. Mol. Sci. 2020, 21(8), 2951. DOI: 10.3390/ijms21082951.
   PubMed Web of Science ®Google Scholar
• Khanna, R. Clinical Presentation & Management of Glomerular Diseases: Hematuria, Nephritic & Nephrotic Syndrome. Mo. Med. 2011, 108(1), 33–36.
   PubMedGoogle Scholar
• Radi, Z. A. Kidney Pathophysiology, Toxicology, and Drug-Induced Injury in Drug Development. Int. J. Toxicol. 2019, 38(3), 215–227. DOI: 10.1177/1091581819831701.
   PubMedGoogle Scholar
• Yan, L.-J. Folic Acid-Induced Animal Model of Kidney Disease. Anim. Model Exp. Med. 2021, 4(4), 329–342. DOI: 10.1002/ame2.12194.
   PubMedGoogle Scholar
• Jenssen, T. G. Efficacy and Safety of Sodium-Glucose-Transporter-2 Inhibitors in Kidney Transplant Patients. Curr. Opin. Nephrol. Hypertens. 2021, 30(6), 577–583. DOI: 10.1097/MNH.0000000000000749.
   PubMedGoogle Scholar
• Capolongo, G.; Capasso, G.; Viggiano, D. A Shared Nephroprotective Mechanism for Renin-Angiotensin-System Inhibitors, Sodium-Glucose Co-Transporter 2 Inhibitors, and Vasopressin Receptor Antagonists: Immunology Meets Hemodynamics. Int. J. Mol. Sci. 2022, 23(7), 3915. DOI: 10.3390/ijms23073915.
   PubMedGoogle Scholar
• Sharma, N.; Anders, H.-J.; Gaikwad, A. B. Fiend and Friend in the Renin Angiotensin System: An Insight on Acute Kidney Injury. Biomed. Pharmacother. 2019, 110, 764–774. DOI: 10.1016/j.biopha.2018.12.018.
   PubMed Web of Science ®Google Scholar
• Liew, A. Perspectives in Renal Replacement Therapy: Haemodialysis. Nephrol. Carlton Vic 2018, 23(Suppl S4), 95–99. DOI: 10.1111/nep.13449.
   PubMedGoogle Scholar
• Lai, X.; Zheng, X.; Mathew, J. M.; Gallon, L.; Leventhal, J. R.; Zhang, Z. J. Tackling Chronic Kidney Transplant Rejection: Challenges and Promises. Front. Immunol. 2021, 12, 661643. DOI: 10.3389/fimmu.2021.661643.
   PubMed Web of Science ®Google Scholar
• Salehi, B.; Venditti, A.; Sharifi-Rad, M.; Kręgiel, D.; Sharifi-Rad, J.; Durazzo, A.; Lucarini, M.; Santini, A.; Souto, E. B.; Novellino, E., et al. The Therapeutic Potential of Apigenin. Int. J. Mol. Sci. 2019, 20(6), 1305. DOI: 10.3390/ijms20061305.
   PubMed Web of Science ®Google Scholar
• Jang, J. Y.; Sung, B.; Kim, N. D. Role of Induced Programmed Cell Death in the Chemopreventive Potential of Apigenin. Int. J. Mol. Sci. 2022, 23(7), 3757. DOI: 10.3390/ijms23073757.
   PubMedGoogle Scholar
• Thomas, S. D.; Jha, N. K.; Jha, S. K.; Sadek, B.; Ojha, S. Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin. Nutrients. 2023, 15(2), 385. DOI: 10.3390/nu15020385.
   PubMed Web of Science ®Google Scholar
• Shankar, E.; Goel, A.; Gupta, K.; Gupta, S. Plant Flavone Apigenin: An Emerging Anticancer Agent. Curr. Pharmacol. Rep. 2017, 3(6), 423–446. DOI: 10.1007/s40495-017-0113-2.
   PubMedGoogle Scholar
• Graf, J. Herbal Anti-Inflammatory Agents for Skin Disease. Skin Ther. Lett. 2000, 5(4), 3–5.
   PubMedGoogle Scholar
• Mushtaq, Z.; Sadeer, N. B.; Hussain, M.; Mahwish Alsagaby, S. A.; Imran, M.; Mumtaz, T.; Umar, M.; Tauseef, A.; Al Abdulmonem, W. Therapeutical Properties of Apigenin: A Review on the Experimental Evidence and Basic Mechanisms. Int. J. Food Prop. 2023, 26(1), 1914–1939. DOI: 10.1080/10942912.2023.2236329.
   Web of Science ®Google Scholar
• Patel, D.; Shukla, S.; Gupta, S. Apigenin and Cancer Chemoprevention: Progress, Potential and Promise (Review). Int. J. Oncol. 2007, 30(1), 233–245. DOI: 10.3892/ijo.30.1.233.
   PubMed Web of Science ®Google Scholar
• Zhang, J.; Liu, D.; Huang, Y.; Gao, Y.; Qian, S. Biopharmaceutics Classification and Intestinal Absorption Study of Apigenin. Int. J. Pharm. 2012, 436(1), 311–317. DOI: 10.1016/j.ijpharm.2012.07.002.
   PubMedGoogle Scholar
• Abid, R.; Ghazanfar, S.; Farid, A.; Sulaman, S. M.; Idrees, M.; Amen, R. A.; Muzammal, M.; Shahzad, M. K.; Mohamed, M. O.; Khaled, A. A., et al. Pharmacological Properties of 4′, 5, 7-Trihydroxyflavone (Apigenin) and Its Impact on Cell Signaling Pathways. Molecules 2022, 27(13), 4304. DOI: 10.3390/molecules27134304.
   PubMedGoogle Scholar
• Singh, B.; Kumar, A.; Malik, A. K. Flavonoids Biosynthesis in Plants and Its Further Analysis by Capillary Electrophoresis. Electrophoresis. 2017, 38(6), 820–832. DOI: 10.1002/elps.201600334.
   PubMed Web of Science ®Google Scholar
• Chen, P.; Chen, F.; Guo, Z.; Lei, J.; Zhou, B. Recent Advancement in Bioeffect, Metabolism, Stability, and Delivery Systems of Apigenin, a Natural Flavonoid Compound: Challenges and Perspectives. Front. Nutr. 2023, 10, 10. DOI: 10.3389/fnut.2023.1221227.
   Google Scholar
• Cvetanović, A. Chapter 24 - Apigenin. In A Centum of Valuable Plant Bioactives; Mushtaq, M. and Anwar, F., Eds.; Academic Press, 2021; pp. 545–562. DOI: 10.1016/B978-0-12-822923-1.00024-8.
   Google Scholar
• Alam, W.; Rocca, C.; Khan, H.; Hussain, Y.; Aschner, M.; De Bartolo, A.; Amodio, N.; Angelone, T.; Cheang, W. S. Current Status and Future Perspectives on Therapeutic Potential of Apigenin: Focus on Metabolic-Syndrome-Dependent Organ Dysfunction. Antioxidants. 2021, 10(10), 1643. DOI: 10.3390/antiox10101643.
   Web of Science ®Google Scholar
• Fossatelli, L.; Maroccia, Z.; Fiorentini, C.; Bonucci, M. Resources for Human Health from the Plant Kingdom: The Potential Role of the Flavonoid Apigenin in Cancer Counteraction. Int. J. Mol. Sci. 2024, 25(1), 251. DOI: 10.3390/ijms25010251.
   Google Scholar
• DeRango-Adem, E. F.; Blay, J. Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers? Front. Pharmacol. 2021, 12, 681477. DOI: 10.3389/fphar.2021.681477.
   PubMed Web of Science ®Google Scholar
• Zhang, J.; Liu, D.; Huang, Y.; Gao, Y.; Qian, S. Biopharmaceutics Classification and Intestinal Absorption Study of Apigenin. Int. J. Pharm. 2012, 436(1–2), 311–317. DOI: 10.1016/j.ijpharm.2012.07.002.
   PubMedGoogle Scholar
• Zhang, X.; Han, R.; Sun, X.; Li, G.; Yang, Q.; Li, Q.; Gai, W.; Zhang, M.; Chen, L.; Yang, G., et al. The Effect of the Skeleton Structure of Flavanone and Flavonoid on Interaction with Transferrin. Bioorg. Med. Chem. Lett. 2013, 23(24), 6677–6681. DOI: 10.1016/j.bmcl.2013.10.042.
   PubMedGoogle Scholar
• Gradolatto, A.; Basly, J.-P.; Berges, R.; Teyssier, C.; Chagnon, M.-C.; Siess, M.-H.; Canivenc-Lavier, M.-C. Pharmacokinetics and Metabolism of Apigenin in Female and Male Rats After a Single Oral Administration. Drug. Metab. Dispos. Biol. Fate Chem. 2005, 33(1), 49–54. DOI: 10.1124/dmd.104.000893.
   PubMed Web of Science ®Google Scholar
• Wang, M.; Firrman, J.; Liu, L.; Yam, K. A Review on Flavonoid Apigenin: Dietary Intake, ADME, Antimicrobial Effects, and Interactions with Human Gut Microbiota. Biomed Res. Int. 2019, 2019, e7010467. DOI: 10.1155/2019/7010467.
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh, M.; Bakhoda, M. R.; Bahmanpour, Z.; Ilkhani, K.; Zarrabi, A.; Makvandi, P.; Khan, H.; Mazaheri, S.; Darvish, M.; Mirzaei, H. Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms with Emphasis on Pancreatic Cancer. Front. Chem. 2020, 8, 8. DOI: 10.3389/fchem.2020.00829.
   PubMedGoogle Scholar
• Griffiths, L. A.; Smith, G. E. Metabolism of Apigenin and Related Compounds in the Rat. Metabolite Formation in vivo and by the Intestinal Microflora in vitro. Biochem. J. 1972, 128(4), 901–911. DOI: 10.1042/bj1280901.
   PubMed Web of Science ®Google Scholar
• Tang, D.; Chen, K.; Huang, L.; Li, J. Pharmacokinetic Properties and Drug Interactions of Apigenin, a Natural Flavone. Expert Opin. Drug. Metab. Toxicol. 2017, 13(3), 323–330. DOI: 10.1080/17425255.2017.1251903.
   PubMed Web of Science ®Google Scholar
• Kashyap, D.; Sharma, A.; Tuli, H. S.; Sak, K.; Garg, V. K.; Buttar, H. S.; Setzer, W. N.; Sethi, G. Apigenin: A Natural Bioactive Flavone-Type Molecule with Promising Therapeutic Function. J. Funct. Foods 2018, 48, 457–471. DOI: 10.1016/j.jff.2018.07.037.
   Google Scholar
• Cicek, M.; Unsal, V.; Doganer, A.; Demir, M. Investigation of Oxidant/Antioxidant and Anti-Inflammatory Effects of Apigenin on Apoptosis in Sepsis-Induced Rat Lung. J. Biochem. Mol. Toxicol. 2021, 35(5), e22743. DOI: 10.1002/jbt.22743.
   PubMed Web of Science ®Google Scholar
• Bhosale, P. B.; Kim, H. H.; Abusaliya, A.; Jeong, S. H.; Park, M. Y.; Kim, H.-W.; Seong, J. K.; Ahn, M.; Park, K. I.; Heo, J. D., et al. Inhibition of Cell Proliferation and Cell Death by Apigetrin Through Death Receptor-Mediated Pathway in Hepatocellular Cancer Cells. Biomolecules. 2023, 13(7), 1131. DOI: 10.3390/biom13071131.
   PubMed Web of Science ®Google Scholar
• Yang, J.; Pi, C.; Wang, G. Inhibition of PI3K/Akt/mTOR Pathway by Apigenin Induces Apoptosis and Autophagy in Hepatocellular Carcinoma Cells. Biomed. Pharmacother. 2018, 103, 699–707. DOI: 10.1016/j.biopha.2018.04.072.
   PubMed Web of Science ®Google Scholar
• Kuru Bektaşoğlu, P.; Demir, D.; Koyuncuoğlu, T.; Yüksel, M.; Peker Eyüboğlu, İ.; Karagöz Köroğlu, A.; Akakın, D.; Yıldırım, A.; Çelikoğlu, E.; Gürer, B. Possible Anti-Inflammatory, Antioxidant, and Neuroprotective Effects of Apigenin in the Setting of Mild Traumatic Brain Injury: An Investigation. Immunopharmacol. Immunotoxicol. 2023, 45(2), 185–196. DOI: 10.1080/08923973.2022.2130076.
   PubMedGoogle Scholar
• Adham, A. N.; Abdelfatah, S.; Naqishbandi, A. M.; Mahmoud, N.; Efferth, T. Cytotoxicity of Apigenin Toward Multiple Myeloma Cell Lines and Suppression of iNOS and COX-2 Expression in STAT1-Transfected HEK293 Cells. Phytomed. Int. J. Phytother. Phytopharm. 2021, 80, 153371. DOI: 10.1016/j.phymed.2020.153371.
   PubMedGoogle Scholar
• Cavalier, A. N.; Clayton, Z. S.; Wahl, D.; Hutton, D. A.; McEntee, C. M.; Seals, D. R.; LaRocca, T. J. Protective Effects of Apigenin on the Brain Transcriptome with Aging. Mech. Ageing Dev. 2024, 217, 111889. DOI: 10.1016/j.mad.2023.111889.
   PubMedGoogle Scholar
• Shu, N.; Zhang, Z.; Wang, X.; Li, R.; Li, W.; Liu, X.; Zhang, Q.; Jiang, Z.; Tao, L.; Zhang, L., et al. Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization. Invest. Ophthalmol. Vis. Sci. 2023, 64(5), 21. DOI: 10.1167/iovs.64.5.21.
   PubMedGoogle Scholar
• Weng, X.; Luo, X.; Dai, X.; Lv, Y.; Zhang, S.; Bai, X.; Bao, X.; Wang, Y.; Zhao, C.; Zeng, M., et al. Apigenin Inhibits Macrophage Pyroptosis Through Regulation of Oxidative Stress and the NF-Κb Pathway and Ameliorates Atherosclerosis. Phytother. Res. PTR. 2023, 37(11), 5300–5314. DOI: 10.1002/ptr.7962.
   PubMedGoogle Scholar
• Jin, Z.; Tian, L.; Zhang, Y.; Zhang, X.; Kang, J.; Dong, H.; Huang, N.; Pan, L.; Ning, B. Apigenin Inhibits Fibrous Scar Formation After Acute Spinal Cord Injury Through TGFβ/SMADs Signaling Pathway. CNS Neurosci. Ther. 2022, 28(11), 1883–1894. DOI: 10.1111/cns.13929.
   PubMedGoogle Scholar
• Lu, J.; Meng, Z.; Cheng, B.; Liu, M.; Tao, S.; Guan, S. Apigenin Reduces the Excessive Accumulation of Lipids Induced by Palmitic Acid via the AMPK Signaling Pathway in HepG2 Cells. Exp. Ther. Med. 2019, 18(4), 2965–2971. DOI: 10.3892/etm.2019.7905.
   PubMedGoogle Scholar
• Wu, L.; Guo, T.; Deng, R.; Liu, L.; Yu, Y. Apigenin Ameliorates Insulin Resistance and Lipid Accumulation by Endoplasmic Reticulum Stress and SREBP-1c/SREBP-2 Pathway in Palmitate-Induced HepG2 Cells and High-Fat Diet–Fed Mice. J. Pharmacol. Exp. Ther. 2021, 377(1), 146–156. DOI: 10.1124/jpet.120.000162.
   PubMed Web of Science ®Google Scholar
• Pan, F.-F.; Shao, J.; Shi, C.-J.; Li, Z.-P.; Fu, W.-M.; Zhang, J.-F. Apigenin Promotes Osteogenic Differentiation of Mesenchymal Stem Cells and Accelerates Bone Fracture Healing via Activating Wnt/β-Catenin Signaling. Am. J. Physiol. Endocrinol. Metab. 2021, 320(4), E760–E771. DOI: 10.1152/ajpendo.00543.2019.
   PubMed Web of Science ®Google Scholar
• Banerjee, K.; Banerjee, S.; Das, S.; Mandal, M. Probing the Potential of Apigenin Liposomes in Enhancing Bacterial Membrane Perturbation and Integrity Loss. J. Colloid. Interface Sci. 2015, 453, 48–59. DOI: 10.1016/j.jcis.2015.04.030.
   PubMed Web of Science ®Google Scholar
• Khandelwal, N.; Chander, Y.; Kumar, R.; Riyesh, T.; Dedar, R. K.; Kumar, M.; Gulati, B. R.; Sharma, S.; Tripathi, B. N.; Barua, S., et al. Antiviral Activity of Apigenin Against Buffalopox: Novel Mechanistic Insights and Drug-Resistance Considerations. Antiviral Res. 2020, 181, 104870. DOI: 10.1016/j.antiviral.2020.104870.
   PubMed Web of Science ®Google Scholar
• Tsiailanis, A. D.; Tellis, C. C.; Papakyriakopoulou, P.; Kostagianni, A. D.; Gkalpinos, V.; Chatzigiannis, C. M.; Kostomitsopoulos, N.; Valsami, G.; Tselepis, A. D.; Tzakos, A. G. Development of a Novel Apigenin Dosage Form as a Substitute for the Modern Triple Antithrombotic Regimen. Mol. Basel Switz. 2023, 28(5), 2311. DOI: 10.3390/molecules28052311.
   Google Scholar
• Yue, S.; Xue, N.; Li, H.; Huang, B.; Chen, Z.; Wang, X. Hepatoprotective Effect of Apigenin Against Liver Injury via the Non-Canonical NF-Κb Pathway in vivo and in vitro. Inflammation. 2020, 43(5), 1634–1648. DOI: 10.1007/s10753-020-01238-5.
   PubMed Web of Science ®Google Scholar
• Wang, X.; Zhao, J.; Li, Y.; Rao, J.; Xu, G. Epigenetics and Endoplasmic Reticulum in Podocytopathy During Diabetic Nephropathy Progression. Front. Immunol. 2022, 13, 13. DOI: 10.3389/fimmu.2022.1090989.
   Google Scholar
• Arora, M. K.; Singh, U. K. Molecular Mechanisms in the Pathogenesis of Diabetic Nephropathy: An Update. Vascul. Pharmacol. 2013, 58(4), 259–271. DOI: 10.1016/j.vph.2013.01.001.
   PubMed Web of Science ®Google Scholar
• Hu, Q.; Jiang, L.; Yan, Q.; Zeng, J.; Ma, X.; Zhao, Y. A Natural Products Solution to Diabetic Nephropathy Therapy. Pharmacol. Ther. 2023, 241, 108314. DOI: 10.1016/j.pharmthera.2022.108314.
   PubMed Web of Science ®Google Scholar
• Jin, Q.; Liu, T.; Qiao, Y.; Liu, D.; Yang, L.; Mao, H.; Ma, F.; Wang, Y.; Peng, L.; Zhan, Y. Oxidative Stress and Inflammation in Diabetic Nephropathy: Role of Polyphenols. Front. Immunol. 2023, 14, 14. DOI: 10.3389/fimmu.2023.1185317.
   Google Scholar
• Malik, S.; Suchal, K.; Khan, S. I.; Bhatia, J.; Kishore, K.; Dinda, A. K.; Arya, D. S. Apigenin Ameliorates Streptozotocin-Induced Diabetic Nephropathy in Rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-Fibronectin Pathways. Am. J. Physiol. Renal Physiol. 2017, 313(2), F414–F422. DOI: 10.1152/ajprenal.00393.2016.
   PubMed Web of Science ®Google Scholar
• Hou, Y.; Zhang, Y.; Lin, S.; Yu, Y.; Yang, L.; Li, L.; Wang, W. Protective Mechanism of Apigenin in Diabetic Nephropathy is Related to Its Regulation of MiR-423-5P-USF2 Axis. Am. J. Transl. Res. 2021, 13(4), 2006–2020.
   PubMed Web of Science ®Google Scholar
• Ogura, Y.; Kitada, M.; Xu, J.; Monno, I.; Koya, D. CD38 Inhibition by Apigenin Ameliorates Mitochondrial Oxidative Stress Through Restoration of the Intracellular NAD+/NADH Ratio and Sirt3 Activity in Renal Tubular Cells in Diabetic Rats. Aging. 2020, 12(12), 11325–11336. DOI: 10.18632/aging.103410.
   PubMedGoogle Scholar
• Zhang, J.; Zhao, X.; Zhu, H.; Wang, J.; Ma, J.; Gu, M. Apigenin Protects Against Renal Tubular Epithelial Cell Injury and Oxidative Stress by High Glucose via Regulation of NF-E2-Related Factor 2 (Nrf2) Pathway. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res 2019, 25, 5280–5288. DOI: 10.12659/MSM.915038.
   Google Scholar
• Saleh Aldayel, T. Apigenin Attenuates High-Fat Diet-Induced Nephropathy in Rats by Hypoglycemic and Hypolipidemic Effects, and Concomitant Activation of the Nrf2/Antioxidant Axis. J. Funct. Foods. 2022, 99, 105295. DOI: 10.1016/j.jff.2022.105295.
   Google Scholar
• Johnson, R. J.; Bakris, G. L.; Borghi, C.; Chonchol, M. B.; Feldman, D.; Lanaspa, M. A.; Merriman, T. R.; Moe, O. W.; Mount, D. B.; Sanchez Lozada, L. G., et al. Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. Am. J. Kidney Dis. Off. J. Natl. Kidney Found 2018, 71(6), 851–865. DOI: 10.1053/j.ajkd.2017.12.009.
   PubMed Web of Science ®Google Scholar
• El Ridi, R.; Tallima, H. Physiological Functions and Pathogenic Potential of Uric Acid: A Review. J. Adv. Res 2017, 8(5), 487–493. DOI: 10.1016/j.jare.2017.03.003.
   PubMed Web of Science ®Google Scholar
• Li, Y.; Zhao, Z.; Luo, J.; Jiang, Y.; Li, L.; Chen, Y.; Zhang, L.; Huang, Q.; Cao, Y.; Zhou, P., et al. Apigenin Ameliorates Hyperuricemic Nephropathy by Inhibiting URAT1 and GLUT9 and Relieving Renal Fibrosis via the Wnt/β-Catenin Pathway. Phytomed. Int. J. Phytother. Phytopharm. 2021, 87, 153585. DOI: 10.1016/j.phymed.2021.153585.
   PubMedGoogle Scholar
• Liu, T.; Gao, H.; Zhang, Y.; Wang, S.; Lu, M.; Dai, X.; Liu, Y.; Shi, H.; Xu, T.; Yin, J., et al. Apigenin Ameliorates Hyperuricemia and Renal Injury Through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharm. Basel Switz 2022, 15(11), 1442. DOI: 10.3390/ph15111442.
   Google Scholar
• Zhu, J.-X.; Yang, H.-Y.; Hu, W.-Q.; Cheng, J.; Liu, Y.; Yi, L.-T.; Cheng, H.-Y. Active Components from Lagotis Brachystachya Maintain Uric Acid Homeostasis by Inhibiting Renal TLR4-NLRP3 Signaling in Hyperuricemic Mice. Inflammopharmacology. 2021, 29(4), 1187–1200. DOI: 10.1007/s10787-021-00844-5.
   PubMed Web of Science ®Google Scholar
• Zhang, C.; Zhao, M.; Jiang, B.; Yu, J.; Hao, Q.; Liu, W.; Hu, Z.; Zhang, Y.; Song, C. Extraction Optimization, Structural Characterization and Potential Alleviation of Hyperuricemia by Flavone Glycosides from Celery Seeds. Food Funct. 2022, 13(19), 9832–9846. DOI: 10.1039/d2fo01715f.
   PubMedGoogle Scholar
• Fan, H.; Liu, J.; Sun, J.; Feng, G.; Li, J. Advances in the Study of B Cells in Renal Ischemia-Reperfusion Injury. Front. Immunol. 2023, 14, 14. DOI: 10.3389/fimmu.2023.1216094.
   Google Scholar
• Smith, S. F.; Hosgood, S. A.; Nicholson, M. L. Ischemia-Reperfusion Injury in Renal Transplantation: 3 Key Signaling Pathways in Tubular Epithelial Cells. Kidney Int. 2019, 95(1), 50–56. DOI: 10.1016/j.kint.2018.10.009.
   PubMed Web of Science ®Google Scholar
• Pefanis, A.; Ierino, F. L.; Murphy, J. M.; Cowan, P. J. Regulated Necrosis in Kidney Ischemia-Reperfusion Injury. Kidney Int. 2019, 96(2), 291–301. DOI: 10.1016/j.kint.2019.02.009.
   PubMed Web of Science ®Google Scholar
• Liu, Y.; Liu, X.; Wang, L.; Du, Y.; Chen, Z.; Chen, H.; Guo, J.; Weng, X.; Wang, X.; Wang, M., et al. Effects of Apigenin on the Expression Levels of B-Cell Lymphoma-2, Fas and Fas Ligand in Renal Ischemia-Reperfusion Injury in Rats. Exp. Ther. Med. 2017, 14(6), 5345–5354. DOI: 10.3892/etm.2017.5241.
   PubMedGoogle Scholar
• Liu, Y.; Wang, L.; Du, Y.; Chen, Z.; Guo, J.; Weng, X.; Wang, X.; Wang, M.; Chen, D.; Liu, X. Effects of Apigenin Pretreatment Against Renal Ischemia/Reperfusion Injury via Activation of the JAK2/STAT3 Pathway. Biomed. Pharmacother. 2017, 95, 1799–1808. DOI: 10.1016/j.biopha.2017.09.091.
   PubMed Web of Science ®Google Scholar
• Wang, X.; Wang, W.; Wang, J.-Z.; Yang, C.; Liang, C.-Z. Effect of Apigenin on Apoptosis Induced by Renal Ischemia/Reperfusion Injury in vivo and in vitro. Ren. Fail. 2018, 40(1), 498–505. DOI: 10.1080/0886022X.2018.1497517.
   PubMed Web of Science ®Google Scholar
• Liu, Y.; Liu, X.; Du, Y.; Chen, Z.; Chen, H.; Guo, J.; Weng, X.; Wang, X.; Wang, M.; Wang, Z., et al. Combination of Apigenin and Ischemic Postconditioning Protects Against Renal Ischemia/Reperfusion Injury in Rat by Inhibiting TLR4/NF-Κb Signaling Pathway.
   Google Scholar
• He, X.; Wen, Y.; Wang, Q.; Wang, Y.; Zhang, G.; Wu, J.; Li, Z.; Wen, J. Apigenin Nanoparticle Attenuates Renal Ischemia/Reperfusion Inflammatory Injury by Regulation of MiR-140-5p/CXCL12/NF-Κb Signaling Pathway. J. Biomed. Nanotechnol. 2021, 17(1), 64–77. DOI: 10.1166/jbn.2021.3010.
   PubMedGoogle Scholar
• Song, L.; Zhang, W.; Tang, S.-Y.; Luo, S.-M.; Xiong, P.-Y.; Liu, J.-Y.; Hu, H.-C.; Chen, Y.-Q.; Jia, B.; Yan, Q.-H., et al. Natural Products in Traditional Chinese Medicine: Molecular Mechanisms and Therapeutic Targets of Renal Fibrosis and State-Of-The-Art Drug Delivery Systems. Biomed. Pharmacother. 2024, 170, 116039. DOI: 10.1016/j.biopha.2023.116039.
   PubMedGoogle Scholar
• Sun, T.; Li, S.; Li, X.; Lei, Y.; Wang, B.; Liu, X.; Yu, S.; Li, N. Apigenin Intervenes in Liver Fibrosis by Regulating PKM2-HIF-1α Mediated Oxidative Stress. Biochem. Biophys. Res. Commun. 2024, 721, 150130. DOI: 10.1016/j.bbrc.2024.150130.
   PubMedGoogle Scholar
• Kan, H.; Wang, P.; Yang, Y.; Jia, H.; Liu, A.; Wang, M.; Ouyang, C.; Yang, X. Apigenin Inhibits Proliferation and Differentiation of Cardiac Fibroblasts Through AKT/GSK3β Signaling Pathway. J. Ethnopharmacol. 2024, 334, 118518. DOI: 10.1016/j.jep.2024.118518.
   PubMedGoogle Scholar
• Li, P.; Fang, R.-L.; Wang, W.; Zeng, X.-X.; Lan, T.; Liu, S.-Y.; Hu, Y.-J.; Shen, Q.; Wang, S.-W.; Tong, Y.-H., et al. Apigenin Suppresses Epithelial-Mesenchymal Transition in High Glucose-Induced Retinal Pigment Epithelial Cell by Inhibiting CBP/p300-Mediated Histone Acetylation. Biochem. Biophys. Res. Commun. 2024, 717, 150061. DOI: 10.1016/j.bbrc.2024.150061.
   PubMedGoogle Scholar
• Wei, X.; Gao, P.; Pu, Y.; Li, Q.; Yang, T.; Zhang, H.; Xiong, S.; Cui, Y.; Li, L.; Ma, X., et al. Activation of TRPV4 by Dietary Apigenin Antagonizes Renal Fibrosis in Deoxycorticosterone Acetate (DOCA)-Salt-Induced Hypertension. Clin. Sci. 2017, 131(7), 567–581. DOI: 10.1042/CS20160780.
   Web of Science ®Google Scholar
• Li, N.; Wang, Z.; Sun, T.; Lei, Y.; Liu, X.; Li, Z. Apigenin Alleviates Renal Fibroblast Activation Through AMPK and ERK Signaling Pathways in vitro. Curr. Pharm. Biotechnol. 2020, 21(11), 1107–1118. DOI: 10.2174/1389201021666200320140908.
   PubMedGoogle Scholar
• Siddiqi, A.; Rani, M.; Bansal, P.; Rizvi, M. M. A. Renal Cell Carcinoma Management: A Step to Nano-Chemoprevention. Life Sci. 2022, 308, 120922. DOI: 10.1016/j.lfs.2022.120922.
   PubMed Web of Science ®Google Scholar
• Capitanio, U.; Bensalah, K.; Bex, A.; Boorjian, S. A.; Bray, F.; Coleman, J.; Gore, J. L.; Sun, M.; Wood, C.; Russo, P. Epidemiology of Renal Cell Carcinoma. Eur. Urology. 2019, 75(1), 74–84. DOI: 10.1016/j.eururo.2018.08.036.
   PubMed Web of Science ®Google Scholar
• Lyskjær, I.; Iisager, L.; Axelsen, C. T.; Nielsen, T. K.; Dyrskjøt, L.; Fristrup, N. Management of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the Clinic. Clin. Cancer Res. 2024, 30(4), 663–672. DOI: 10.1158/1078-0432.CCR-23-1892.
   PubMedGoogle Scholar
• Meng, S.; Zhu, Y.; Li, J.-F.; Wang, X.; Liang, Z.; Li, S.-Q.; Xu, X.; Chen, H.; Liu, B.; Zheng, X.-Y., et al. Apigenin Inhibits Renal Cell Carcinoma Cell Proliferation. Oncotarget. 2017, 8(12), 19834–19842. DOI: 10.18632/oncotarget.15771.
   PubMedGoogle Scholar
• Bao, Y.; Wu, X.; Jin, X.; Kanematsu, A.; Nojima, M.; Kakehi, Y.; Yamamoto, S. Apigenin Inhibits Renal Cell Carcinoma Cell Proliferation Through G2/M Phase Cell Cycle Arrest. Oncol. Rep. 2022, 47(3), 60. DOI: 10.3892/or.2022.8271.
   PubMedGoogle Scholar
• Li, J.; Tan, G.; Cai, Y.; Liu, R.; Xiong, X.; Gu, B.; He, W.; Liu, B.; Ren, Q.; Wu, J., et al. A Novel Apigenin Derivative Suppresses Renal Cell Carcinoma via Directly Inhibiting Wild-Type and Mutant MET. Biochem. Pharmacol. 2021, 190, 114620. DOI: 10.1016/j.bcp.2021.114620.
   PubMedGoogle Scholar
• Yan, X.; Qi, M.; Li, P.; Zhan, Y.; Shao, H. Apigenin in Cancer Therapy: Anti-Cancer Effects and Mechanisms of Action. Cell. Biosci. 2017, 7(1), 50. DOI: 10.1186/s13578-017-0179-x.
   PubMed Web of Science ®Google Scholar
• Xu, Y.; Xin, Y.; Diao, Y.; Lu, C.; Fu, J.; Luo, L.; Yin, Z.; Sarkar, F. H. Synergistic Effects of Apigenin and Paclitaxel on Apoptosis of Cancer Cells. PLOS ONE. 2011, 6(12), e29169. DOI: 10.1371/journal.pone.0029169.
   PubMed Web of Science ®Google Scholar
• Lee, S. H.; Ryu, J. K.; Lee, K.-Y.; Woo, S. M.; Park, J. K.; Yoo, J. W.; Kim, Y.-T.; Yoon, Y. B. Enhanced Anti-Tumor Effect of Combination Therapy with Gemcitabine and Apigenin in Pancreatic Cancer. Cancer Lett. 2008, 259(1), 39–49. DOI: 10.1016/j.canlet.2007.09.015.
   PubMed Web of Science ®Google Scholar
• Gaballah, H. H.; Gaber, R. A.; Mohamed, D. A. Apigenin Potentiates the Antitumor Activity of 5-FU on Solid Ehrlich Carcinoma: Crosstalk Between Apoptotic and JNK-Mediated Autophagic Cell Death Platforms. Toxicol. Appl. Pharmacol. 2017, 316, 27–35. DOI: 10.1016/j.taap.2016.12.012.
   PubMed Web of Science ®Google Scholar
• Sen, K.; Banerjee, S.; Mandal, M. Dual Drug Loaded Liposome Bearing Apigenin and 5-Fluorouracil for Synergistic Therapeutic Efficacy in Colorectal Cancer. Colloids Surf. B Biointerfaces. 2019, 180, 9–22. DOI: 10.1016/j.colsurfb.2019.04.035.
   PubMed Web of Science ®Google Scholar
• Viljoen, A.; Chaudhry, R.; Bycroft, J. Renal Stones. Ann. Clin. Biochem. 2019, 56(1), 15–27. DOI: 10.1177/0004563218781672.
   PubMed Web of Science ®Google Scholar
• Azimi, A.; Eidi, A.; Mortazavi, P.; Rohani, A. H. Protective Effect of Apigenin on Ethylene Glycol-Induced Urolithiasis via Attenuating Oxidative Stress and Inflammatory Parameters in Adult Male Wistar Rats. Life Sci. 2021, 279, 119641. DOI: 10.1016/j.lfs.2021.119641.
   PubMedGoogle Scholar
• Stiani, S. N.; Syahidah, F. M.; Fikriani, H.; Subarnas, A.; Rusdiana, T. Anticalculi Activity of Apigenin and Celery (Apium Graveolens L.) Extract in Rats Induced by Ethylene Glycol–Ammonium Chloride. J. Pharm. Bioallied Sci. 2019, 11(Suppl 4), S556–S561. DOI: 10.4103/jpbs.JPBS_202_19.
   PubMedGoogle Scholar
• Lin, Q.; Li, S.; Jin, H.; Cai, H.; Zhu, X.; Yang, Y.; Wu, J.; Qi, C.; Shao, X.; Li, J., et al. Mitophagy Alleviates Cisplatin-Induced Renal Tubular Epithelial Cell Ferroptosis Through ROS/HO-1/GPX4 Axis. Int. J. Biol. Sci. 2023, 19(4), 1192–1210. DOI: 10.7150/ijbs.80775.
   PubMed Web of Science ®Google Scholar
• Fang, C.-Y.; Lou, D.-Y.; Zhou, L.-Q.; Wang, J.-C.; Yang, B.; He, Q.-J.; Wang, J.-J.; Weng, Q.-J. Natural Products: Potential Treatments for Cisplatin-Induced Nephrotoxicity. Acta Pharmacol. Sin. 2021, 42(12), 1951–1969. DOI: 10.1038/s41401-021-00620-9.
   PubMed Web of Science ®Google Scholar
• He, X.; Li, C.; Wei, Z.; Wang, J.; Kou, J.; Liu, W.; Shi, M.; Yang, Z.; Fu, Y. Protective Role of Apigenin in Cisplatin-Induced Renal Injury. Eur. J. Pharmacol. 2016, 789, 215–221. DOI: 10.1016/j.ejphar.2016.07.003.
   PubMed Web of Science ®Google Scholar
• Ju, S. M.; Kang, J. G.; Bae, J. S.; Pae, H. O.; Lyu, Y. S.; Jeon, B. H. The Flavonoid Apigenin Ameliorates Cisplatin-Induced Nephrotoxicity Through Reduction of p53 Activation and Promotion of PI3K/Akt Pathway in Human Renal Proximal Tubular Epithelial Cells. Evid.-Based Complement. Altern. Med. ECAM. 2015, 2015, 186436. DOI: 10.1155/2015/186436.
   PubMed Web of Science ®Google Scholar
• Hassan, S. M.; Khalaf, M. M.; Sadek, S. A.; Abo-Youssef, A. M. Protective Effects of Apigenin and Myricetin Against Cisplatin-Induced Nephrotoxicity in Mice. Pharm. Biol. 2017, 55(1), 766–774. DOI: 10.1080/13880209.2016.1275704.
   PubMed Web of Science ®Google Scholar
• Sharma, A.; Sinha, S.; Shrivastava, N. Apigenin and Kaempferol as Novel Renoprotective Agent Against Cisplatin-Induced Toxicity: An in vitro Study. Nat. Prod. Res. 2022, 36(23), 6085–6090. DOI: 10.1080/14786419.2022.2045603.
   PubMedGoogle Scholar
• Arab, H. H.; Abd El-Aal, S. A.; Eid, A. H.; Arafa, E.-S. A.; Mahmoud, A. M.; Ashour, A. M. Targeting Inflammation, Autophagy, and Apoptosis by Troxerutin Attenuates Methotrexate-Induced Renal Injury in Rats. Int. Immunopharmacol. 2022, 103, 108284. DOI: 10.1016/j.intimp.2021.108284.
   PubMedGoogle Scholar
• Sahindokuyucu-Kocasari, F.; Akyol, Y.; Ozmen, O.; Erdemli-Kose, S.; Garli, S. Apigenin Alleviates Methotrexate-Induced Liver and Kidney Injury in Mice. Hum. Exp. Toxicol. 2021, 40(10), 1721–1731. DOI: 10.1177/09603271211009964.
   PubMed Web of Science ®Google Scholar
• Wu, Q.; Chen, J.; Zheng, X.; Song, J.; Yin, L.; Guo, H.; Chen, Q.; Liu, Y.; Ma, Q.; Zhang, H., et al. Kaempferol Attenuates Doxorubicin-Induced Renal Tubular Injury by Inhibiting ROS/ASK1-Mediated Activation of the MAPK Signaling Pathway. Biomed. Pharmacother. 2023, 157, 114087. DOI: 10.1016/j.biopha.2022.114087.
   PubMed Web of Science ®Google Scholar
• Wu, Q.; Li, W.; Zhao, J.; Sun, W.; Yang, Q.; Chen, C.; Xia, P.; Zhu, J.; Zhou, Y.; Huang, G., et al. Apigenin Ameliorates Doxorubicin-Induced Renal Injury via Inhibition of Oxidative Stress and Inflammation. Biomed. Pharmacother. 2021, 137, 111308. DOI: 10.1016/j.biopha.2021.111308.
   PubMed Web of Science ®Google Scholar
• Kang, S.; Chen, T.; Hao, Z.; Yang, X.; Wang, M.; Zhang, Z.; Hao, S.; Lang, F.; Hao, H. Oxymatrine Alleviates Gentamicin-Induced Renal Injury in Rats. Mol. Basel Switz. 2022, 27(19), 6209. DOI: 10.3390/molecules27196209.
   Google Scholar
• Hussein, M. M.; Althagafi, H. A.; Alharthi, F.; Albrakati, A.; Alsharif, K. F.; Theyab, A.; Kassab, R. B.; Mufti, A. H.; Algahtani, M.; Oyouni, A. A. A., et al. Apigenin Attenuates Molecular, Biochemical, and Histopathological Changes Associated with Renal Impairments Induced by Gentamicin Exposure in Rats. Environ. Sci. Pollut. Res. Int. 2022, 29(43), 65276–65288. DOI: 10.1007/s11356-022-20235-9.
   PubMed Web of Science ®Google Scholar
• Huo, X.; Meng, Q.; Wang, C.; Zhu, Y.; Liu, Z.; Ma, X.; Ma, X.; Peng, J.; Sun, H.; Liu, K. Cilastatin Protects Against Imipenem-Induced Nephrotoxicity via Inhibition of Renal Organic Anion Transporters (OATs). Acta Pharm. Sin. B. 2019, 9(5), 986–996. DOI: 10.1016/j.apsb.2019.02.005.
   PubMed Web of Science ®Google Scholar
• Huo, X.; Meng, Q.; Wang, C.; Wu, J.; Zhu, Y.; Sun, P.; Ma, X.; Sun, H.; Liu, K. Targeting Renal OATs to Develop Renal Protective Agent from Traditional Chinese Medicines: Protective Effect of Apigenin Against Imipenem-Induced Nephrotoxicity. Phytother. Res. PTR. 2020, 34(11), 2998–3010. DOI: 10.1002/ptr.6727.
   PubMedGoogle Scholar
• Wu, Q.; Kuca, K. Metabolic Pathway of Cyclosporine a and Its Correlation with Nephrotoxicity. Curr. Drug. Metab. 2019, 20(2), 84–90. DOI: 10.2174/1389200219666181031113505.
   PubMedGoogle Scholar
• Chong, F. W.; Chakravarthi, S.; Nagaraja, H. S.; Thanikachalam, P. M.; Lee, N. Expression of Transforming Growth Factor- and Determination of Apoptotic Index in Histopathological Sections for Assessment of the Effects of Apigenin (4’, 5’, 7’ - Trihydroxyflavone) on Cyclosporine a Induced Renal Damage, 2009.
   Google Scholar
• Gulati, N. M.; Stewart, P. L.; Steinmetz, N. F. Bioinspired Shielding Strategies for Nanoparticle Drug Delivery Applications. Mol. Pharm. 2018, 15(8), 2900–2909. DOI: 10.1021/acs.molpharmaceut.8b00292.
   PubMed Web of Science ®Google Scholar
• Makhdoumi, P.; Karimi, H.; Khazaei, M. Review on Metal-Based Nanoparticles: Role of Reactive Oxygen Species in Renal Toxicity. Chem. Res. Toxicol. 2020, 33(10), 2503–2514. DOI: 10.1021/acs.chemrestox.9b00438.
   PubMed Web of Science ®Google Scholar
• Ali, A. A.-M.; Mansour, A. B.; Attia, S. A. The Potential Protective Role of Apigenin Against Oxidative Damage Induced by Nickel Oxide Nanoparticles in Liver and Kidney of Male Wistar Rat, Rattus norvegicus. Environ. Sci. Pollut. Res. 2021, 28(22), 27577–27592. DOI: 10.1007/s11356-021-12632-3.
   PubMedGoogle Scholar
• Wang, T.; Zhang, Z.; Xie, M.; Li, S.; Zhang, J.; Zhou, J. Apigenin Attenuates Mesoporous Silica Nanoparticles-Induced Nephrotoxicity by Activating FOXO3a. Biol. Trace Elem. Res. 2022, 200(6), 2793–2806. DOI: 10.1007/s12011-021-02871-3.
   PubMedGoogle Scholar
• Zamani, F.; Samiei, F.; Mousavi, Z.; Azari, M. R.; Seydi, E.; Pourahmad, J. Apigenin Ameliorates Oxidative Stress and Mitochondrial Damage Induced by Multiwall Carbon Nanotubes in Rat Kidney Mitochondria. J. Biochem. Mol. Toxicol. 2021, 35(6), 1–7. DOI: 10.1002/jbt.22762.
   PubMedGoogle Scholar
• Petejova, N.; Martinek, A.; Zadrazil, J.; Teplan, V. Acute Toxic Kidney Injury. Ren. Fail. 2019, 41(1), 576–594. DOI: 10.1080/0886022X.2019.1628780.
   PubMed Web of Science ®Google Scholar
• Wang, E.; Chen, F.; Hu, X.; Yuan, Y. Protective Effects of Apigenin Against Furan-Induced Toxicity in Mice. Food Funct. 2014, 5(8), 1804–1812. DOI: 10.1039/c4fo00038b.
   PubMed Web of Science ®Google Scholar
• Zhong, Y.; Jin, C.; Wang, X.; Li, X.; Han, J.; Xue, W.; Wu, P.; Peng, X.; Xia, X. Protective Effects of Apigenin Against 3-MCPD-Induced Renal Injury in Rat. Chem. Biol. Interact. 2018, 296, 9–17. DOI: 10.1016/j.cbi.2018.08.005.
   PubMed Web of Science ®Google Scholar
• Ahmad, A.; Kumari, P.; Ahmad, M. Apigenin Attenuates Edifenphos-Induced Toxicity by Modulating ROS-Mediated Oxidative Stress, Mitochondrial Dysfunction and Caspase Signal Pathway in Rat Liver and Kidney. Pestic. Biochem. Physiol. 2019, 159, 163–172. DOI: 10.1016/j.pestbp.2019.06.010.
   PubMed Web of Science ®Google Scholar
• Kang, H.-K.; Ecklund, D.; Liu, M.; Datta, S. K. Apigenin, a Non-Mutagenic Dietary Flavonoid, Suppresses Lupus by Inhibiting Autoantigen Presentation for Expansion of Autoreactive Th1 and Th17 Cells. Arthritis Res. Ther. 2009, 11(2), R59. DOI: 10.1186/ar2682.
   PubMed Web of Science ®Google Scholar
• Almaghrabi, S. Y. Apigenin Ameliorates Hypercholesterolemic-Induced Kidney Injury via Modulating Renal KIM-1, Fn1, and Nrf2 Signaling Pathways.
   Google Scholar
• Jeon, B.-J.; Yang, H.-M.; Lyu, Y.-S.; Pae, H.-O.; Ju, S.-M.; Jeon, B.-H. Apigenin Inhibits Indoxyl Sulfate-Induced Endoplasmic Reticulum Stress and Anti-Proliferative Pathways, CHOP and IL-6/p21, in Human Renal Proximal Tubular Cells. Eur. Rev. Med. Pharmacol. Sci. 2015, 19(12), 2303–2310.
   PubMedGoogle Scholar
• Fehaid, A.; Al-Ghamdi, M. S.; Alzahrani, K. J.; Theyab, A.; Al-Amer, O. M.; Al-Shehri, S. S.; Algahtani, M.; Oyouni, A. A.; Alnfiai, M. M.; Aly, M. H., et al. Apigenin Protects from Hepatorenal Damage Caused by Lead Acetate in Rats. J. Biochem. Mol. Toxicol. 2023, 37(3), e23275. DOI: 10.1002/jbt.23275.
   PubMedGoogle Scholar
• Kramer, D. J.; Johnson, A. A. Apigenin: A Natural Molecule at the Intersection of Sleep and Aging. Front. Nutr. 2024, 11. DOI: 10.3389/fnut.2024.1359176.
   PubMedGoogle Scholar
• Amsterdam, J. D.; Li, Q. S.; Xie, S. X.; Mao, J. J. Putative Antidepressant Effect of Chamomile (Matricaria Chamomilla L.) Oral Extract in Subjects with Comorbid Generalized Anxiety Disorder and Depression. The J. Alternative Complement. Med. Sep 18, 2020, 26(9), 815–821. DOI: 10.1089/acm.2019.0252.
   Google Scholar
• Zargaran, A.; Borhani-Haghighi, A.; Salehi-Marzijarani, M.; Faridi, P.; Daneshamouz, S.; Azadi, A.; Sadeghpour, H.; Sakhteman, A.; Mohagheghzadeh, A. Evaluation of the Effect of Topical Chamomile (Matricaria Chamomilla L.) Oleogel as Pain Relief in Migraine without Aura: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Neurol. Sci. 2018, 39(8), 1345–1353. DOI: 10.1007/s10072-018-3415-1.
   PubMedGoogle Scholar
• Shoara, R.; Hashempur, M. H.; Ashraf, A.; Salehi, A.; Dehshahri, S.; Habibagahi, Z. Efficacy and Safety of Topical Matricaria Chamomilla L. (Chamomile) Oil for Knee Osteoarthritis: A Randomized Controlled Clinical Trial. Complement. Ther. Clin. Pract. 2015, 21(3), 181–187. DOI: 10.1016/j.ctcp.2015.06.003.
   PubMed Web of Science ®Google Scholar
• Choi, S.; Youn, J.; Kim, K.; Joo, D. H.; Shin, S.; Lee, J.; Lee, H. K.; An, I.-S.; Kwon, S.; Youn, H. J., et al. Apigenin Inhibits UVA-Induced Cytotoxicity in vitro and Prevents Signs of Skin Aging in vivo. Int. J. Mol. Med. 2016, 38(2), 627–634. DOI: 10.3892/ijmm.2016.2626.
   PubMed Web of Science ®Google Scholar
• Hoensch, H.; Groh, B.; Edler, L.; Kirch, W. Prospective Cohort Comparison of Flavonoid Treatment in Patients with Resected Colorectal Cancer to Prevent Recurrence. World J. Gastroenterol. 2008, 14(14), 2187–2193. DOI: 10.3748/wjg.14.2187.
   PubMedGoogle Scholar
• Li, L.; Gu, L.; Chen, Z.; Wang, R.; Ye, J.; Jiang, H. Toxicity Study of Ethanolic Extract of Chrysanthemum Morifolium in Rats. J. Food Sci. 2010, 75(6), T105–109. DOI: 10.1111/j.1750-3841.2010.01702.x.
   PubMedGoogle Scholar
• Divya Rajaselvi, N.; Jida, M. D.; Nair, D. B.; Sujith, S.; Beegum, N.; Nisha, A. R. Toxicity Prediction and Analysis of Flavonoid Apigenin as a Histone Deacetylase Inhibitor: An in-Silico Approach. Silico Pharmacol. 2023, 11(1), 34. DOI: 10.1007/s40203-023-00170-4.
   PubMedGoogle Scholar
• Nielsen, S. E.; Young, J. F.; Daneshvar, B.; Lauridsen, S. T.; Knuthsen, P.; Sandström, B.; Dragsted, L. O. Effect of Parsley (Petroselinum Crispum) Intake on Urinary Apigenin Excretion, Blood Antioxidant Enzymes and Biomarkers for Oxidative Stress in Human Subjects. Br. J. Nutr. 1999, 81(6), 447–455. DOI: 10.1017/S000711459900080X.
   PubMed Web of Science ®Google Scholar
• Janssen, K.; Mensink, R. P.; Cox, F. J.; Harryvan, J. L.; Hovenier, R.; Hollman, P. C.; Katan, M. B. Effects of the Flavonoids Quercetin and Apigenin on Hemostasis in Healthy Volunteers: Results from an in vitro and a Dietary Supplement Study. Am. J. Clin. Nutr. 1998, 67(2), 255–262. DOI: 10.1093/ajcn/67.2.255.
   PubMed Web of Science ®Google Scholar
• Singh, P.; Mishra, S. K.; Noel, S.; Sharma, S.; Rath, S. K.; Ahmad, A. Acute Exposure of Apigenin Induces Hepatotoxicity in Swiss Mice. PLOS ONE. 2012, 7(2), e31964. DOI: 10.1371/journal.pone.0031964.
   PubMed Web of Science ®Google Scholar
• Saeed, M.; Kadioglu, O.; Khalid, H.; Sugimoto, Y.; Efferth, T. Activity of the Dietary Flavonoid, Apigenin, Against Multidrug-Resistant Tumor Cells as Determined by Pharmacogenomics and Molecular Docking. J. Nutr. Biochem. 2015, 26(1), 44–56. DOI: 10.1016/j.jnutbio.2014.09.008.
   PubMedGoogle Scholar
• Zhang, D.-Y.; Zu, Y.-G.; Fu, Y.-J.; Luo, M.; Wang, W.; Gu, C.-B.; Zhao, C.-J.; Jiao, J.; Efferth, T. Enzyme Pretreatment and Negative Pressure Cavitation Extraction of Genistein and Apigenin from the Roots of Pigeon Pea [Cajanus Cajan (L.) Millsp.] and the Evaluation of Antioxidant Activity. Ind. Crops Prod. 2012, 37(1), 311–320. DOI: 10.1016/j.indcrop.2011.12.026.
   Google Scholar
• Sen, K.; Mandal, M. Second Generation Liposomal Cancer Therapeutics: Transition from Laboratory to Clinic. Int. J. Pharm. 2013, 448(1), 28–43. DOI: 10.1016/j.ijpharm.2013.03.006.
   PubMedGoogle Scholar
• Banerjee, K.; Banerjee, S.; Mandal, M. Enhanced Chemotherapeutic Efficacy of Apigenin Liposomes in Colorectal Cancer Based on Flavone-Membrane Interactions. J. Colloid. Interface Sci. 2017, 491, 98–110. DOI: 10.1016/j.jcis.2016.12.025.
   PubMed Web of Science ®Google Scholar
• Bhattacharya, S.; Mondal, L.; Mukherjee, B.; Dutta, L.; Ehsan, I.; Debnath, M. C.; Gaonkar, R. H.; Pal, M. M.; Majumdar, S. Apigenin Loaded Nanoparticle Delayed Development of Hepatocellular Carcinoma in Rats. Nanomed. Nanotechnol. Biol. Med. 2018, 14(6), 1905–1917. DOI: 10.1016/j.nano.2018.05.011.
   PubMed Web of Science ®Google Scholar
• Shukla, R.; Kashaw, S. K.; Jain, A. P.; Lodhi, S. Fabrication of Apigenin Loaded Gellan Gum-Chitosan Hydrogels (GGCH-HGs) for Effective Diabetic Wound Healing. Int. J. Biol. Macromol. 2016, 91, 1110–1119. DOI: 10.1016/j.ijbiomac.2016.06.075.
   PubMed Web of Science ®Google Scholar